Unique ID issued by UMIN | UMIN000059026 |
---|---|
Receipt number | R000067506 |
Scientific Title | Effectiveness of Digital Health Services in Preventing Lifestyle-Related Diseases |
Date of disclosure of the study information | 2025/09/08 |
Last modified on | 2025/09/07 21:54:29 |
Effectiveness of Digital Health Services in Preventing Lifestyle-Related Diseases
Preventive Effect of Digital Technology on Lifestyle-Related Diseases
Effectiveness of Digital Health Services in Preventing Lifestyle-Related Diseases
Preventive Effect of Digital Technology on Lifestyle-Related Diseases
Japan |
Non-communicable diseases
Medicine in general | Cardiology | Endocrinology and Metabolism |
Adult |
Others
NO
This study aims to evaluate the effectiveness of digital health services in preventing lifestyle-related diseases by using digital devices such as smartwatches and smartphone apps.
Efficacy
Body weight, waist circumference, and blood pressure at 3 months.
1-Year Outcomes: Body Weight, Waist Circumference, Blood Glucose, HbA1c, Blood Pressure, and Initiation of Treatment for Diabetes and Hypertension.
Interventional
Parallel
Randomized
Cluster
Open -no one is blinded
Active
2
Prevention
Behavior,custom |
AI feedback is delivered daily via the smartphone app.
AI feedback is delivered weekly via the smartphone app.
40 | years-old | <= |
74 | years-old | >= |
Male and Female
Eligible participants shall be individuals who have provided consent, selected from among those targeted by the "Specific Health Guidance (Active Support and Motivational Support)" and the "Disease Severity Prevention Program," which are implemented by municipalities within the LIFE Study participating regions.
For Participants in the "Specific Health Guidance" Program:
Individuals already receiving medication for lifestyle-related diseases (diabetes, hypertension, or dyslipidemia) are not eligible for inclusion. Furthermore, individuals aged 75 or older are also not considered eligible. No other exclusion criteria will be set for this group.
For Participants in the "Disease Severity Prevention Program":
Individuals aged 75 or older are an exclusion criterion due to feasibility concerns regarding the implementation of the intervention. However, it should be noted that individuals already receiving medication for lifestyle-related diseases (diabetes, hypertension, or dyslipidemia) will not be excluded.
180
1st name | Haruhisa |
Middle name | |
Last name | Fukuda |
Kyushu University
Graduate School of Medical Sociences
812-8582
Higashi-ku, Maidashi 3-1-1, Fukuoka
092-642-6960
fukuda.haruhisa.977@m.kyushu-u.ac.jp
1st name | Haruhisa |
Middle name | |
Last name | Fukuda |
Kyushu University
Graduate School of Medical Sociences
812-8582
Higashi-ku, Maidashi 3-1-1, Fukuoka
092-642-6960
fukuda.haruhisa.977@m.kyushu-u.ac.jp
Kyushu University
Haruhisa Fukuda
JST
Japanese Governmental office
Institutional Review Board for Clinical Research
Higashi-ku, Maidashi 3-1-1, Fukuoka
092-642-5082
byskenkyu@jimu.kyushu-u.ac.jp
NO
2025 | Year | 09 | Month | 08 | Day |
Unpublished
Preinitiation
2025 | Year | 09 | Month | 01 | Day |
2025 | Year | 10 | Month | 01 | Day |
2028 | Year | 09 | Month | 30 | Day |
2025 | Year | 09 | Month | 07 | Day |
2025 | Year | 09 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067506